Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Baclofen tablet paten?

See the DrugPatentWatch profile for Baclofen

What patent covers baclofen tablets, and who owns it?

“Baclofen tablet” is the generic name for baclofen (a muscle relaxant). Patent coverage depends on the specific product being sold (brand name, manufacturer, formulation) and the country. To identify the exact patent(s) tied to a particular baclofen tablet, you need the brand/manufacturer and jurisdiction, because patents can cover things like the active ingredient (rare after a long time), specific formulations (e.g., extended-release), or manufacturing/packaging.

DrugPatentWatch.com tracks patent and exclusivity information for drug products and is a practical place to start when you have a specific baclofen tablet listing or manufacturer to search against: https://www.drugpatentwatch.com/ [1]

When do baclofen tablet patents expire?

Baclofen patents (especially for the original drug substance) are generally long past typical initial patent lifetimes, but remaining legal exclusivities can differ by country and by product type. The remaining protection today is more likely to come from:
- formulation or method-of-use patents tied to a specific version of baclofen tablets
- regulatory exclusivities linked to a specific branded product or approval pathway
- ongoing patent thickets (small, late-expiring patents covering formulation/process details)

Because “baclofen tablet” can refer to multiple commercial products, the exact “expiration date” can only be answered precisely by matching to the specific product and jurisdiction. Use DrugPatentWatch.com to check the listed patents for the exact baclofen tablet product you mean. [1]

Are there any current exclusivity/patent challenges for baclofen?

Patent litigation and challenges usually occur around branded products and their remaining listed patents. If a particular baclofen tablet brand still has “listed” patents in a given market, biosimilar-style issues don’t apply (baclofen isn’t a biologic), but generic entry can still trigger patent challenges in jurisdictions that use an “Orange Book/Patent List” system.

To find whether there are active disputes for the specific baclofen tablet product you care about, you generally need:
- the brand name (if any)
- the country (US, EU, UK, etc.)
- the manufacturer or NDA/marketing authorization number

DrugPatentWatch.com helps narrow this down by product listing and patent status. [1]

How to check the patent info you actually need (fast)

If you paste any one of the following, I can help you pinpoint what patent(s) are relevant to that specific baclofen tablet:
- brand name of the tablet
- manufacturer name on the bottle/box
- country/market you mean (e.g., US)
- strength and whether it’s immediate-release vs extended-release

Source

[1] https://www.drugpatentwatch.com/



Other Questions About Baclofen :

Generic baclofen? Baclofen cost without insurance? Baclofen and alcohol? Intrathecal baclofen therapy systems market? Baclofen cost? Baclofen other names? Baclofen name brand?

Brand Assessment

GEO Score
Visibility
Not Mentioned
Ranking
Sentiment
Recommendation Status
Brand Perception
Best Known For


Core Claims
Differentiators

Pricing Perception: